Patent application number | Description | Published |
20140348879 | ENTERIC SOFT CAPSULES - A gel mass is provided that is useful for manufacturing enteric soft capsules without coating. | 11-27-2014 |
20150108033 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE ACTIVE INGREDIENTS - Described herein are pharmaceutical compositions for the delivery of poorly soluble active pharmaceutical ingredients. In particular, a substantially clear fexofenadine HCl solution in a soft gelatin capsule is described. | 04-23-2015 |
20150118298 | ENTERIC SOFT CAPSULES COMPRISING POLYUNSATURATED FATTY ACIDS - Described herein are pharmaceutical compositions comprising polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules comprising omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and high triglyceride levels. | 04-30-2015 |
20150246016 | CONTROLLED RELEASE ENTERIC SOFT CAPSULES OF FUMARATE ESTERS - Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising controlled release enteric soft capsules and matrices comprising fumarate esters are described. | 09-03-2015 |
20150283087 | ABUSE-DETERRENT CONTROLLED RELEASE FORMULATIONS - Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described. | 10-08-2015 |
20150366813 | LIQUID-FILLED IMMEDIATE RELEASE SOFT GELATIN CAPSULES - Described herein are oral pharmaceutical compositions comprising labile, air-, moisture-, or heat-sensitive active pharmaceutical ingredients and methods for making the same. In particular, immediate release capsules comprising non-aqueous fills comprising moisture-sensitive active pharmaceutical ingredients are described. | 12-24-2015 |
20160000740 | ENHANCED BIOAVAILABILITY OF POLYUNSATURATED FATTY ACIDS - Described herein are pharmaceutical compositions providing enhanced bioavailability of polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules that provide enhanced bioavailability of omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and moderate to high triglyceride levels. | 01-07-2016 |
20160101059 | CONTROLLED RELEASE ENTERIC SOFT CAPSULES OF FUMARATE ESTERS - Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising controlled release enteric soft capsules and matrices comprising fumarate esters are described. | 04-14-2016 |
20160106682 | Enteric Soft Capsules - A gel mass is provided that is useful in manufacturing enteric soft or hard capsules, or enteric tablets without coating. | 04-21-2016 |